-
Business

S&P 500, Nasdaq Hit Record Highs on AI Momentum and Fed Rate Cut Signals
The S&P 500 and Nasdaq notched fresh record closes Friday, driven by AI sector gains, dovish Fed signals, and easing…
Read More » -
Business

McGraw Hill Files for IPO as Platinum Equity Seeks Exit from $4.5B Bet
McGraw Hill has filed for a U.S. IPO, aiming to reenter public markets with a recurring-revenue model and a tech-forward…
Read More » -
Business

Terrafina Drops CIBanco After U.S. Treasury Sanctions
Terrafina has removed CIBanco as its trustee following U.S. Treasury sanctions over alleged fentanyl-related money laundering. The move signals growing…
Read More » -
Business

UK Tribunal Rules Mastercard and Visa Broke Competition Law Over Card Fees
In a major blow to global payments giants, Mastercard and Visa have been found to have violated competition law in…
Read More » -
Business

Gavin Newsom Sues Fox News for $787M Over Edited Trump Call Clip
California Gov. Gavin Newsom is suing Fox News for $787 million over a segment he claims falsely portrayed him lying…
Read More » -
Business

Mexico Seizes Oversight of Banks After U.S. Fentanyl Sanctions
Mexico’s financial regulator has taken temporary control of CIBanco and Intercam Banco after the U.S. Treasury hit them with sanctions…
Read More » -
Business

White House: Trump Hasn’t Decided on Replacing Fed Chair Powell—Yet
The White House says President Trump has not decided on replacing Federal Reserve Chair Jerome Powell. Still, markets are reacting…
Read More » -
Business

Vasi Philomin Exits AWS, Leaving a Leadership Gap in Amazon’s AI Push
Vasi Philomin, the executive who shaped Amazon’s foundational AI tools, has left AWS after eight years. His exit comes as…
Read More » -
Business

Barclays, Jes Staley to Face U.S. Investors Over Epstein Disclosures
A Los Angeles federal court has allowed a U.S. shareholder lawsuit to move forward against Barclays and ex-CEO Jes Staley.…
Read More » -
Business

Walgreens Beats Q3 Estimates as Sycamore Takeover Nears
Walgreens posted stronger-than-expected earnings in Q3, driven by pharmacy growth and aggressive cost cutting. As the $10B Sycamore deal approaches,…
Read More »









